Sacramento Ear, Nose & Throat Surgical and Medical Group, Inc. is committed to the scientific advancement of medicine and the development of promising new medical treatments. This philosophy has led to the founding of our in-office Clinical Trials Department.
Clinical trials are done to get a closer look at promising new treatments or procedures for patients. A clinical trial is only done when there is good reason to believe that the treatment, test or procedure being studied may be better than the one currently being used. Treatments used in clinical trials are often found to have real benefits and may go on to become tomorrow’s standard treatment. Sacramento Ear, Nose & Throat has participated in a variety of clinical trials, ranging from studying medications for ear infections to relief for chronic sinusitis.
There are also potential benefits for the clinical trial volunteers. Those with existing diseases or conditions can play a more active role in their own health care, gain access to new research treatments before they are widely available and help others by contributing to medical advancement.
Safety is one of the largest concerns for most participants. The pharmaceutical companies that are affiliated with our studies have written protocols that the on-site principal investigator (one of our SacENT physicians) extensively reviews. The Food and Drug Administration oversees each process of the clinical trial and an Institutional Review Board validates each protocol to ensure the rights and safety of each study volunteer is protected.
The Center for Information and Study on Clinical Research Participation has provided useful information for patients and their families to help answer questions they may have regarding participation in a clinical trial. Please see their website at http://www.ciscrp.org for additional information.
If you are interested in participating in a clinical trial, please fill out the form on this page and we will contact you shortly.
You can also learn more about our clinical research team by clicking here.